Antibiotics, Antineoplastic
"Antibiotics, Antineoplastic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms.
Descriptor ID |
D000903
|
MeSH Number(s) |
D27.505.954.248.106
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antibiotics, Antineoplastic".
Below are MeSH descriptors whose meaning is more specific than "Antibiotics, Antineoplastic".
This graph shows the total number of publications written about "Antibiotics, Antineoplastic" by people in this website by year, and whether "Antibiotics, Antineoplastic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 5 | 2 | 7 |
1995 | 9 | 2 | 11 |
1996 | 14 | 5 | 19 |
1997 | 11 | 2 | 13 |
1998 | 9 | 5 | 14 |
1999 | 7 | 2 | 9 |
2000 | 7 | 7 | 14 |
2001 | 12 | 4 | 16 |
2002 | 6 | 6 | 12 |
2003 | 5 | 4 | 9 |
2004 | 9 | 12 | 21 |
2005 | 16 | 4 | 20 |
2006 | 8 | 9 | 17 |
2007 | 11 | 4 | 15 |
2008 | 8 | 9 | 17 |
2009 | 4 | 12 | 16 |
2010 | 6 | 7 | 13 |
2011 | 6 | 4 | 10 |
2012 | 8 | 6 | 14 |
2013 | 8 | 6 | 14 |
2014 | 9 | 7 | 16 |
2015 | 7 | 3 | 10 |
2016 | 3 | 3 | 6 |
2017 | 7 | 5 | 12 |
2018 | 2 | 1 | 3 |
2019 | 5 | 3 | 8 |
2020 | 5 | 4 | 9 |
2021 | 6 | 4 | 10 |
2022 | 0 | 3 | 3 |
2023 | 0 | 6 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antibiotics, Antineoplastic" by people in Profiles.
-
Circulating microRNAs and Cytokines as Prognostic Biomarkers for Doxorubicin-Induced Cardiac Injury and for Evaluating the Effectiveness of an Exercise Intervention. Clin Cancer Res. 2023 11 01; 29(21):4430-4440.
-
Early skeletal muscle loss in adolescent and young adult cancer patients treated with anthracycline chemotherapy. Cancer Med. 2023 11; 12(22):20798-20809.
-
Inhibition of Galectin-9 sensitizes tumors to anthracycline treatment via inducing antitumor immunity. Int J Biol Sci. 2023; 19(14):4644-4656.
-
Anthracycline-induced cardiotoxicity - are we about to clear this hurdle? Eur J Cancer. 2023 05; 185:94-104.
-
Dexrazoxane and Long-Term Heart Function in Survivors of Childhood Cancer. J Clin Oncol. 2023 04 20; 41(12):2248-2257.
-
Evaluation of the Sensitivity to Endocrine Therapy Index and 21-Gene Breast Recurrence Score in the SWOG S8814 Trial. J Clin Oncol. 2023 04 01; 41(10):1841-1848.
-
Cardioprotection Using Strain-Guided Management of Potentially Cardiotoxic?Cancer Therapy: 3-Year Results of the SUCCOUR Trial. JACC Cardiovasc Imaging. 2023 03; 16(3):269-278.
-
Risk factors for cardiovascular events and mortality in patients diagnosed with diffuse large B-cell lymphoma and treated with anthracyclines. Hematol Oncol. 2022 Oct; 40(4):626-636.
-
Pregnancy outcomes related to the treatment of sarcomas with anthracyclines and/or ifosfamide during pregnancy. Cancer Med. 2022 09; 11(18):3471-3478.
-
Durability of Response to Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma Using UGN-101, a Mitomycin-Containing Reverse Thermal Gel: OLYMPUS Trial Final Report. J Urol. 2022 Apr; 207(4):779-788.